This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, R. E. Articles by Peterson, R. G. Search for Related Content PubMed PubMed Citation Articles by Schmidt, R. E. Articles by Peterson, R. G.

(American Journal of Pathology. 2003;163:21-28.)
© 2003 American Society for Investigative Pathology

Short Communication

Analysis of the Zucker Diabetic Fatty (ZDF) Type 2 Diabetic Rat Model Suggests a Neurotrophic Role for Insulin/IGF-I in Diabetic Autonomic Neuropathy

Robert E. Schmidt^*, Denise A. Dorsey^*, Lucie N. Beaudet^* and Richard G. Peterson

Department of Pathology and Immunology,^* Division of Neuropathology, Washington University School of Medicine, Saint Louis, Missouri, and the Department of Anatomy, Indiana University School of Medicine, Indianapolis, Indiana

Dysfunction of the autonomic nervous system is a recognized complication of diabetes. Neuroaxonal dystrophy (NAD), a distinctive axonopathy involving distal axons and synapses, represents the neuropathologic hallmark of diabetic sympathetic autonomic neuropathy in human and several insulinopenic experimental rodent models. Recent studies have suggested that loss of the neurotrophic effects of insulin and/or IGF-I on sympathetic neurons and not hyperglycemia per se, may underlie the development of sympathetic NAD. The streptozotocin (STZ)-diabetic and BB/W rat, the most commonly used experimental rodent models, develop marked hyperglycemia and concomitant deficiency in both circulating insulin and IGF-I. These animals reproducibly develop NAD in nerve terminals in the prevertebral sympathetic ganglia and the distal portions of noradrenergic ileal mesenteric nerves. The Zucker Diabetic Fatty (ZDF) rat, an animal model of type 2 diabetes, also develops severe hyperglycemia comparable to that in the STZ- and BB/W-diabetic rat models, although in the presence of hyperinsulinemia. In our study, ZDF rats maintained for 6 to 7 months in a severely diabetic state, as assessed by plasma glucose and glycated hemoglobin levels, maintained significant hyperinsulinemia and normal levels of plasma IGF-I at sacrifice. NAD did not develop in diabetic ZDF rat sympathetic ganglia and ileal mesenteric nerves as assessed by quantitative ultrastructural techniques, which is in dramatic contrast to neuropathologic findings in comparably hyperglycemic 6-month STZ-diabetic insulinopenic rats. These data combined with our previous results argue very strongly that hyperglycemia is not the critical and sufficient element in the pathogenesis of diabetes-induced NAD, rather that it is the loss of trophic support, most likely of IGF-I or insulin, that causes NAD.

This article has been cited by other articles:

				S. Reinwald, R. G. Peterson, M. R. Allen, and D. B. Burr Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E765 - E774. [Abstract] [Full Text] [PDF]

				V. Brussee, G. Guo, Y. Dong, C. Cheng, J. A. Martinez, D. Smith, G. W. Glazner, P. Fernyhough, and D. W. Zochodne Distal Degenerative Sensory Neuropathy in a Long-Term Type 2 Diabetes Rat Model Diabetes, June 1, 2008; 57(6): 1664 - 1673. [Abstract] [Full Text] [PDF]

				L. A. Lesniewski, A. J. Donato, B. J. Behnke, C. R. Woodman, M. H. Laughlin, C. A. Ray, and M. D. Delp Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1840 - H1850. [Abstract] [Full Text] [PDF]

				M. J. Stevens, W. Zhang, F. Li, and A. A. F. Sima C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E497 - E505. [Abstract] [Full Text] [PDF]

				A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko Diabetic Somatic Neuropathies Diabetes Care, June 1, 2004; 27(6): 1458 - 1486. [Full Text] [PDF]

				A. P. Mizisin Comparative Neuropathology and Diabetic Autonomic Neuropathy Am. J. Pathol., November 1, 2003; 163(5): 1703 - 1706. [Full Text] [PDF]

				R. E. Schmidt, D. A. Dorsey, L. N. Beaudet, K. E. Frederick, C. A. Parvin, S. B. Plurad, and M. G. Levisetti Non-Obese Diabetic Mice Rapidly Develop Dramatic Sympathetic Neuritic Dystrophy: A New Experimental Model of Diabetic Autonomic Neuropathy Am. J. Pathol., November 1, 2003; 163(5): 2077 - 2091. [Abstract] [Full Text] [PDF]